A review of the monitoring of argatroban by anti-IIa methods, ecarin assays, point-of-care testing methods and specialized drug quantification methods for patients with heparin-induced thrombocytopenia.
- DOI
- 10.1097/mbc.0000000000001470
- Published
- 2026 Nov 6
- Container
- Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/mbc.0000000000001470,
title = {A review of the monitoring of argatroban by anti-IIa methods, ecarin assays, point-of-care testing methods and specialized drug quantification methods for patients with heparin-induced thrombocytopenia.},
author = {Guy S and Horner K and Leeson K and Maclean R},
year = {2026},
journal = {Blood coagulation \& fibrinolysis : an international journal in haemostasis and thrombosis},
doi = {10.1097/mbc.0000000000001470},
url = {https://doi.org/10.1097/mbc.0000000000001470}
}RIS
TY - JOUR TI - A review of the monitoring of argatroban by anti-IIa methods, ecarin assays, point-of-care testing methods and specialized drug quantification methods for patients with heparin-induced thrombocytopenia. AU - Guy S AU - Horner K AU - Leeson K AU - Maclean R PY - 2026 JO - Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis DO - 10.1097/mbc.0000000000001470 UR - https://doi.org/10.1097/mbc.0000000000001470 ER -
APA
S, G., K, H., K, L., & R, M. (2026). A review of the monitoring of argatroban by anti-IIa methods, ecarin assays, point-of-care testing methods and specialized drug quantification methods for patients with heparin-induced thrombocytopenia.. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis. https://doi.org/10.1097/mbc.0000000000001470
Source records
- pubmed · retrieved 2026-11-10T18:56:13.237Z